Should Potassium Citrate and Sambong Be Stopped After KUB Ultrasound Shows Cleared Kidney Stones?
No, potassium citrate should generally NOT be stopped immediately after stones clear, as kidney stone recurrence rates are extremely high (26-53% at 5 years), and potassium citrate is one of the most effective preventive therapies available. 1
Understanding Stone Clearance vs. Prevention
The critical distinction here is between acute stone treatment (getting rid of current stones) and preventive therapy (stopping new stones from forming). Just because imaging shows no stones doesn't mean the underlying metabolic problem causing stones has resolved.
Why Continue Potassium Citrate?
Potassium citrate is a proven preventive medication, not just an acute treatment. The evidence shows:
- Number needed to treat is approximately 2-3 patients over 3 years to prevent one recurrence - this is exceptionally effective 2
- In randomized trials, potassium citrate reduced 3-year stone recurrence from 60-80% down to 10-30% 2
- Long-term therapy (up to 14 years studied) maintains durable metabolic changes and decreases stone formation rate by 93% 3
- After shockwave lithotripsy with stone clearance, patients on potassium citrate had 0% recurrence at 12 months versus 28.5% in untreated patients 4
The AUA guidelines (2014, reaffirmed in 2026) specifically recommend potassium citrate for patients with recurrent calcium stones and low urinary citrate as standard therapy (Grade B evidence). 5, 6, 7
Decision Algorithm for Stopping Medications
Continue Potassium Citrate If:
- Patient has had recurrent stones (more than one episode)
- 24-hour urine shows hypocitraturia (low citrate) or other metabolic abnormalities
- Patient is high-risk: solitary kidney, large stone burden, calcium phosphate stones, or ongoing metabolic syndrome
- Stone-free period is less than 2-3 years for radiopaque stones or less than 3-5 years for radiolucent stones 1
Consider Stopping Potassium Citrate Only If:
- First-time stone former with normal metabolic workup
- Patient has been stone-free for 2-3+ years on therapy with normalized urinary parameters 1
- Follow-up 24-hour urine shows sustained correction of metabolic abnormalities
- Patient experiences significant side effects (hyperkalemia, GI disturbances) 8
Important caveat: The EAU guidelines suggest stone-free patients could potentially be discharged from imaging follow-up after 2 years for radiopaque stones or 3 years for radiolucent stones, but this refers to imaging surveillance, not necessarily stopping preventive medications. 1
What About Sambong?
Sambong (herbal supplement) has weak evidence and should be discontinued once stones clear.
- A 2016 systematic review found herbal remedies inferior to citrate therapy for stone prevention 9
- Citrate was significantly more effective than phytotherapy in decreasing stone size and urinary urate excretion 9
- Herbal preparations containing Didymocarpus pedicellata showed some benefit, but sambong specifically lacks robust clinical trial data
- Unlike potassium citrate, sambong has no established role in long-term prevention
Monitoring Strategy After Stone Clearance
If continuing potassium citrate (which you should in most cases):
- Obtain 24-hour urine within 6 months of starting therapy to assess metabolic response 5
- Annual 24-hour urine thereafter to monitor adherence and efficacy 5
- Periodic blood tests to monitor for hyperkalemia, especially in patients with impaired renal function 8
- Follow-up imaging based on stone type and risk factors, not medication decisions 1
Critical Safety Warnings for Potassium Citrate
Avoid or closely monitor potassium citrate in patients with:
- Chronic kidney disease or impaired potassium excretion
- Heart failure or severe myocardial damage
- Concurrent use of potassium-sparing diuretics or ACE inhibitors
Potentially fatal hyperkalemia can develop rapidly and be asymptomatic. 8
Bottom Line
Stop sambong immediately after stone clearance - it has minimal evidence. However, continue potassium citrate for long-term prevention unless the patient is a first-time stone former with normal metabolic workup who has been stone-free for 2-3+ years, or has contraindications to therapy. The recurrence rate without preventive therapy is simply too high (26-53% at 5 years), and potassium citrate is one of the most effective interventions available with an NNT of only 2-3 patients.